The pathophysiology of heart failure is complex, but mitochondrial dysfunction is an emerging therapeutic target to improve cardiac function. In this Consensus Statement, insights into the ...

Objective Heart failure is a growing challenge to healthcare systems worldwide. Technological solutions have the potential to improve the health of patients and help to reduce costs. Acceptability is ...

Studies of the epidemiology of heart failure in the general population can inform assessments of disease burden, research, public health policy and health system care delivery. We performed a ...

Patients with type 2 diabetes mellitus are at a higher risk of developing heart failure compared with the healthy population. In recent landmark clinical trials, sodium-glucose co-transporter 2 (SGLT2 ...

Cite this: Natriuretic Peptides in Heart Failure: Should Therapy be Guided by BNP Levels? - Medscape - Jan 01, 2010. ... Boston, MA 02115, USA (M. O'Donoghue, E. Braunwald).

Abbreviations: HF, heart failure; NT-proBNP, N-terminal proB-type natriuretic peptide. ... Michelle O'Donoghue and Eugene Braunwald TIMI Study Group, Cardiovascular Division, ...